Washington D.C., Jun 9, 2023 / 14:40 pm
The Maryland Board of Public Works approved nearly $1.3 million in emergency spending to pay for a stockpile of two abortion drugs in response to a lawsuit that could take one of the drugs off the market.
Most of the spending will support two contracts to purchase 30,000 doses of mifepristone, which can kill an unborn child up to 10 weeks’ gestation.
Alliance for Hippocratic Medicine challenged the Food and Drug Administration’s 2000 approval of the drug and subsequent deregulation in court, claiming that the agency failed to follow proper protocol and ignored potential health risks.
A Texas judge suspended the FDA’s approval of the drug, but the agency appealed the ruling. The Supreme Court ruled that the drug will remain on the market, pending the outcome of the appeal.